Table 1 Characteristics of the lung adenocarcinoma patients included in the current study
Cohort | TVGHa (%) | TCGAa (%) |
|---|---|---|
N = 69 (100 %) | N = 299 (100 %) | |
Age | ||
< 65 year-old | 25 (36.2 %) | 124 (41.5 %) |
≥ 65 year-old | 44 (63.8 %) | 166 (55.5 %) |
Stage | ||
Stage IA | 13 (18.8 %) | 113 (37.8 %) |
Stage IB | 42 (60.9 %) | 104 (34.8 %) |
Stage IIA | 4 (5.8 %) | 32 (10.7 %) |
Stage IIB | 10 (14.5 %) | 50 (16.7 %) |
T stage | ||
Stage 1 | 16 (23.2 %) | 122 (40.8 %) |
Stage 2 | 51 (73.9 %) | 159 (53.2 %) |
Stage 3 | 2 (2.9 %) | 18 (6.0 %) |
N stage | ||
N0 | 56 (81.2 %) | 236 (78.9 %) |
≥ N1 | 12 (17.4 %) | 57 (19.1 %) |
M stage | ||
M0 | 69 (100 %) | 299 (100 %) |
≥ M1 | 0 (0.0 %) | 0 (0.0 %) |
Surgery | ||
Lobectomy | 60 (87.0 %) | -b |
Wedge resection | 8 (11.6 %) | -b |
Segmentectomy | 1 (1.4 %) | -b |
Chemotherapy | ||
No | 51 (73.9 %) | -b |
Yes | 15 (21.7 %) | -b |
TKI treatment | ||
No | 62 (89.9 %) | -b |
Yes | 6 (8.7 %) | -b |